In the current study, we have investigated for the first time the antimicrobial properties of 5 propolis extracts obtained from different regions of Colombia against isolates of Staphylococcus spp.
Propolis: Five samples of propolis from Apis mellifera beehives were collected from different regions (Fusagasuga-Cundinamarca, located at 1.
PVA samples with propolis were also tested to compare them with the PVA-NaCMC-propolis samples.
The samples' phenols and flavonoids delivery, as well as DPPH activity, were statistically evaluated by ANOVA one-way analysis (95% level of confidence), where the factor analyzed was the amount of propolis with 4 levels (0%, 3%, 15%, and 30% propolis).
In the search for new organic formulations that help to control phytopathogens, and taking into consideration that the composition of propolis
varies with flowering and harvesting period, the objective of this research was to check the effect of seasonality on the antifungal potential of different concentrations of ethanolic extract of green propolis
on the post-harvest phytopathogen Lasiodiplodia theobromae.
Category (a): receiving sequentially combined treatment with Propolis
2h before Dacarbazine Category (b): receiving simultaneous treatment with Propolis
and Dacarbazine at the same time.
To our knowledge, no prior study has investigated the mineral composition of propolis
produced by different collectors.
is produced by bees from a resin of a native species of the Northeast of Brazil, Dalbergia ecastophyllum L.
20 g of each crude propolis
was extracted with 250 ml ethanohwater 80:20 (v/v) at room temperature during 7 days.
The aim of this study was to evaluate the pollen composition of Sonoran propolis
obtained from the central Sonoran apicultural production area (Ures, Sonora) and to determine its relationship with the regional vegetation and the effect of seasonality on frequency and amount of pollen loads.
Scientific opinion on the substantion of health claims related to propolis
(ID 1242, 1245-1248, 3184) and flavonoids in propolis
(ID 1244, 1644, 1645, 3526, 3527, 3798, 3799) pursuant to article 13 (1) of Regulation (EC) No 1924/2006.
Extracts of propolis
have demonstrated several activities on the CNS.